Goldman Sachs Upgrades Porsche to Buy: 911 Portfolio Optimization + Cost Cutting Drive Valuation Repair

Overview

Goldman Sachs upgrades Porsche AG rating from Neutral to Buy with a 12-month target price of €59, implying approx. 24% upside vs. the current share price of €47.73. Although the company faces structural headwinds such as product portfolio gaps (ICE 718 and Macan discontinuations) and deteriorating China market conditions, analysts believe these factors have been de-risked through 2025 expectations, and are fully reflected in the current stock price. The core investment thesis revolves around two short-term hedges that the market underestimates: 911 model portfolio normalization and indirect cost reduction. This makes the multi-year EPS recovery path increasingly visible, with EPS CAGR projected at 30% through 2030.

Core views

Demand Side: The 911, as the flagship model in the portfolio, has become the most reliable source to offset product gap pressures. Analysts predict 911 ASP growth of approx. 12% and 5% in FY26/27, far exceeding market consensus of 5.9% and 2.4%, primarily driven by an increasing mix of high-margin derivatives (e.g., GT3, Turbo S) in the 992.2 generation. This makes the 911 the most credible short-term earnings hedge against overall volume decline, with overall ASP expected to grow by 10.4% and 5.1% in FY26/27. Cost Side: New management has demonstrated clear intent to cut costs by divesting non-core assets (e.g., Bugatti Rimac stake) and streamlining the executive team. SG&A expenses reached 12.9% of revenue in FY25, significantly higher than peers like Ferrari (9.0%), BMW (7.9%), and Mercedes-Benz (9.2%), offering room for reversion to historical levels. Analysts expect the second cost plan to reduce SG&A to 11.1% by 2028. Furthermore, indirect cost personnel are not covered by employment guarantee agreements, meaning cuts may occur faster than market expectations. Valuation & Forecasts: Based on 911 ASP growth and cost optimization measures, analysts adjust FY26/27/28 EPS forecasts by 13.7%/-2.1%/11.7%, respectively. They raise the valuation multiple from 15x to 20x (applied to FY27/28 blended EPS), raising the target price from €39 to €59. Despite expected volume declines of 10% and 2% in FY26/27, primarily due to ICE 718 and Macan discontinuations and China market challenges, 911 ASP growth and cost optimization are sufficient to offset these pressures. China deliveries are projected to further drop to approx. 28k and 23k units, but their share of total deliveries has fallen to 11% and 9.5%, representing significantly lower risk exposure than European peers (BMW 24%/24%, Mercedes-Benz 27%/26%). Catalysts: The Autumn 2026 CMD will serve as a key catalyst, where the company is expected to disclose a structural path for margin recovery. The goal is to achieve approx. 15% group EBIT margins by FY2030 (Goldman Sachs forecast 14.1%), with a return to double-digit group margins by 2028.

Analysis framework

Analysts support the upgrade view by identifying two underestimated hedges. First, they analyze the historical maturity pattern of the 911 model portfolio, considering supplier force majeure impacts on the 992.2 generation (leading to initial deliveries skewed toward base models), predicting 911 ASP growth of approx. 12% and 5% in FY26/27. Second, they benchmark Porsche's SG&A expense ratio against peers like Ferrari, BMW, and Mercedes-Benz, finding significant room for indirect cost optimization. They note that only 76.5% of employees are covered by the 2030 employment guarantee agreement, creating conditions for rapid cuts. Finally, applying a 20x target P/E (up from 15x) to FY27/28 blended EPS yields a €59 target price. This multiple implies approx. 14.5x P/E for FY29E, consistent with the historical median of approx. 15x, reflecting confidence in the recovery pace rather than permanent revaluation.

Methodology notes

• Valuation MethodologyPE/PEG valuation

  Forward P/E Valuation

  Analysts calculate target price by multiplying target P/E multiple by forecasted EPS. This report raises Porsche's target P/E from 15x to 20x, applied to FY27/28 blended EPS, reflecting enhanced confidence in the EPS recovery path rather than a permanent valuation re-rating.

• Industry/Industrial Analysis FrameworkVolume-price decomposition

  Volume and ASP Decomposition Analysis

  Analysts decompose revenue growth into volume changes and average selling price (ASP) changes. Although Porsche volume is expected to decline in FY26/27, ASP increases driven by 911 portfolio optimization (approx. 12%/5%) can partially offset volume pressure. This is a key framework for understanding profitability resilience in luxury automotive brands.

• Company Fundamentals and Financial FrameworkOperating/Financial Leverage Analysis

  Indirect Cost Leverage Analysis

  Analysts compare Porsche's SG&A as a % of revenue against peers (12.9% vs. peers' 7.9%-9.2%) to identify indirect cost reduction space. This expense ratio benchmarking is a common method for assessing operational efficiency and margin recovery potential.

• Event Gaming and Behavioral FinanceExpectation Gap/Expectation Management

  Market Expectation De-risking Analysis

  Analysts point out that Porsche's structural headwinds (volume decline, China deterioration) have been fully priced in through 2025 expectation adjustments, with current stock prices reflecting most negative factors. This expectation gap analysis is a crucial method for valuing repair opportunities.

• Industry/Industrial Analysis FrameworkProduct life cycle

  Portfolio Maturity Analysis

  Analysts examine the maturity trajectory of each 911 generation, noting that the 992.2 generation launched in early 2024 was skewed toward base models due to supplier issues. It is expected to reach a mature mix by 2027 (increased share of high-margin derivatives). This product lifecycle analysis aids in forecasting ASP trends.

• Valuation Methodology

  Historical Median Valuation Benchmarking

  Analysts compare the implied FY29E valuation (14.5x) from the target P/E against the historical median (approx. 15x) to assess current valuation fairness. This historical benchmarking serves as an important reference for determining valuation repair space.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• Porsche AG (P911-P.DE / P911-D.DE)

  Beneficiary: 911 portfolio optimization and cost cutting drive EPS recovery, with valuation repairing from 15x to 20x

  Strengths

  911 models possess strong brand premium and pricing power; Base Carrera pricing CAGR since 1997 reaches 2.2%; high-end derivative CAGR reaches 5.0%. Significant indirect cost reduction space (SG&A 12.9% vs. peers 7.9%-9.2%)

  Weaknesses

  Product portfolio gaps (ICE 718 and Macan discontinuations), continued China market deterioration, margin dilution from EV transition

  Comparison

  Lower China market risk exposure than European peers (Porsche 11%/9.5% vs. BMW 24%/24%, Mercedes-Benz 27%/26%); Higher SG&A ratio than peers but with room for reversion

  Risks

  New product launch delays, intensified competition eroding pricing power, EV margins below expectations, further China market deterioration, raw material supply disruptions

Key data

• 12-Month Target Price€59.00Implies approx. 24% upside vs. current price of €47.73
• FY26/27 Volume Change-10%/-2%Impacted by product portfolio gaps and China market deterioration
• 911 ASP Growth (FY26/27)Approx. 12%/5%Significantly exceeds market consensus of 5.9%/2.4%
• Overall ASP Growth (FY26/27)10.4%/5.1%Driven by 911 portfolio optimization
• SG&A as % of Revenue (FY25)12.9%Higher than peers: Ferrari 9.0%, BMW 7.9%, Mercedes-Benz 9.2%
• SG&A Target (2028)11.1%Target of indirect cost reduction plan
• EPS CAGR (2026-2030)30%Goldman Sachs forecast multi-year EPS recovery path
• FY26/27/28 EPS Adjustment13.7%/-2.1%/11.7%Based on ASP growth and cost measures
• China Market Deliveries (FY26/27)Approx. 28k/23k unitsSignificant decline from 93k units in FY22
• China Market Share (FY26/27)11%/9.5%Risk exposure significantly reduced
• Target P/E20xRaised from 15x, applied to FY27/28 blended EPS
• Group EBIT Margin Target (2030)Approx. 15%Goldman Sachs forecast FY30 at 14.1%
• Operating Margin Recovery (2028)Return to double digitsGoldman Sachs forecasts Group EBIT margin of 10.7%

Impact & implications

For Porsche, this recovery path means the company can maintain profitability amidst short-term volume pressures through portfolio optimization and cost cutting, providing investors with a clear multi-year EPS recovery trajectory. For the industry, it demonstrates resilience strategies for luxury automotive brands during product transition periods (fuel-to-electric shift): boosting ASP through high-margin derivatives of flagship models (911) while strictly controlling indirect costs. The Autumn CMD will be a critical node to validate the credibility of this recovery path. If the company discloses specific cost-cutting measures and timelines, it will further boost market confidence. Although EV transition and China market competition remain long-term headwinds, risks have significantly eased as China exposure shrinks (from high proportions in FY22 to 11%/9.5% in FY26/27).

Risks

• Delays in new product launches and delivery schedules: Regulatory hurdles, supplier issues, or development setbacks could extend product gaps, delaying volume and margin recovery
• Intensified competition in key segments: Traditional European performance car peers and Chinese EV startups moving upmarket could erode pricing power and ASP growth assumptions
• Slowdown in EV/fuel vehicle delivery growth and supply-demand mismatch: Faster electrification regulatory pushes or slower consumer EV adoption could lead to inventory imbalances, triggering EV price cuts and premature fuel vehicle exits
• Profitability decline due to delivery shortfalls or EV gross margins below expectations: If EV unit economics disappoint due to battery costs, platform economics, or competitive pricing pressures, the 911 portfolio normalization hedge may be insufficient to sustain group margin targets
• Continued deterioration of China operations: Further adjustments to luxury tax thresholds, intensified competition from Chinese luxury OEMs, or weak macroeconomic conditions could cause China deliveries to fall significantly below baseline scenarios
• Failure in raw material supply security: Geopolitical tensions, export restrictions, or concentration risks in procurement could lead to production delays and increased input costs

What to watch

• Details and timelines of cost-cutting measures disclosed in the Autumn 2026 CMD
• Progress on 911 portfolio optimization (speed of increasing high-margin derivative share)
• Execution speed of indirect cost cuts (progress toward SG&A 11.1% target)
• Performance of eCayenne in the European market (expected FY26 deliveries 12k units, FY27 reaching 20k units)
• Trends in China market deliveries and effectiveness of dealer network restructuring (approx. 80 sales points)
• Progress on restoring Group operating margins to double digits by 2028